Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Current Medicinal Chemistry|February 17, 2012
DNA interstrand cross-linking agents and their chemotherapeutic potentialL Brulikova, J Hlavac, P HradilMini Reviews in Medicinal Chemistry|June 13, 2009
3-Hydroxy-2-phenyl-4(1H)-quinolinones as promising biologically active compoundsP Hradil, J Hlavác, M Soural, et al.Neuroimage|October 7, 2006
Pharmacological MRI in awake rats reveals neural activity in area postrema and nucleus tractus solitarius: relevance as a potential biomarker for detecting drug-induced emesisChih-Liang Chin, Gerard B Fox, Vincent P Hradil, et al.Neuroscience|June 7, 2008
Non-invasive characterization of beta-amyloid(1-40) vasoactivity by functional magnetic resonance imaging in miceF Luo, T R Seifert, R Edalji, et al.Synapse (New York, N.Y.)|December 18, 2007
Pharmacological MRI in awake rats predicts selective binding of alpha4beta2 nicotinic receptorsChih-Liang Chin, James R Pauly, Bruce W Surber, et al.Neurobiology of Aging|October 22, 2010
Characterization of 7- and 19-month-old Tg2576 mice using multimodal in vivo imaging: limitations as a translatable model of Alzheimer's diseaseFeng Luo, Nathan R Rustay, Ulrich Ebert, et al.Journal of Magnetic Resonance Imaging : JMRI|September 3, 2002
Evaluation of tissue perfusion in a rat model of hind-limb muscle ischemia using dynamic contrast-enhanced magnetic resonance imagingYanping Luo, Kurt M Mohning, Vincent P Hradil, et al.Journal of Neuroimmunology|April 7, 2009
Distinct spatiotemporal pattern of CNS lesions revealed by USPIO-enhanced MRI in MOG-induced EAE rats implicates the involvement of spino-olivocerebellar pathwaysChih-Liang Chin, Madhavi Pai, Peter F Bousquet, et al.Cancer Chemotherapy and Pharmacology|November 15, 2011
A novel multi-targeted tyrosine kinase inhibitor, linifanib (ABT-869), produces functional and structural changes in tumor vasculature in an orthotopic rat glioma modelYanping Luo, Fang Jiang, Todd B Cole, et al.Anti-Cancer Drugs|April 29, 2009
ABT-751, a novel tubulin-binding agent, decreases tumor perfusion and disrupts tumor vasculatureYanping Luo, Vincent P Hradil, David J Frost, et al.Pageof 2